To "B" or not to "B": efficacy of a neonatal hepatitis B vaccination program to prevent primary liver cancer and end-stage liver disease.

Karnik, Rasika

To "B" or not to "B": efficacy of a neonatal hepatitis B vaccination program to prevent primary liver cancer and end-stage liver disease. [electronic resource] - Gastroenterology May 2015 - 1073-5 p. digital

Publication Type: Journal Article; Comment

1528-0012

10.1053/j.gastro.2015.03.037 doi


Hepatitis B--epidemiology
Hepatitis B virus--immunology
Humans
Liver Diseases--epidemiology
Liver Neoplasms--epidemiology